期刊文献+

高尿酸血症与高血压发生心血管事件的相关性探讨 被引量:24

Study on the relationship between hyperuricemia and cardiovascular events in hypertension
下载PDF
导出
摘要 目的:探讨高尿酸血症与高血压发生心血管事件的相关性。方法:对187例高血压伴高尿酸血症患者,按不同的血压水平(1,2,3级)及心血管事件(心力衰竭、不稳定性心绞痛、急性心肌梗死)分组,分别比较血尿酸的变化。结果:高血压1,2,3级之间血尿酸差异无显著性(P>0.05);高血压伴高尿酸血症发生心血管事件与无心血管事件组相比血尿酸差异有显著性(P<0.05);心血管事件组之间血尿酸差异无显著性(P>0.05)。结论:高尿酸血症与高血压的级别高低无相关性;与高血压发生心血管事件有相关性。 Objective To study the relationship between hyperuricemia and cardiovascular events in hypertension. Methods One hundred and eighty-seven patients with hypertension attendant hyperuricemia were divided in groups according to different blood pressure grades (1, 2, 3 grade) and cardiovascular events (heart failure, unstable angina, acute myocardial infarction). The changes of serum uric acid were compared in different groups. Results Serum uric acid had no significant difference in hypertension 1, 2, 3 grade groups(P〉0. 05) and in cardiovascular events groups (P〉 0.05). Serum uric acid had significant difference (P 〈 0. 05) between hypertension attendant hyperuricemia with cardiovascular events group and without cardiovascular events group. Conclusion Hyperuricemia is not related to the grades of hypertension, but is related to cardiovascular events in hypertension.
出处 《实用诊断与治疗杂志》 2006年第7期505-506,共2页 Journal of Practical Diagnosis and Therapy
关键词 高尿酸血症 高血压 心血管事件 Hyperuricemia hypertension cardiovascular events
  • 相关文献

参考文献11

  • 1Jossa F, Faeinro E, Panico S, et al. Serum uric acid and hypertension: the Olivetti Heart Study[J]. J Hum Hypertens,1994,8(9) :677
  • 2Franse I V, Pahor M, DiBari M, et al. Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program(SHEP)[J]. J Hypertens,2000,18(8):1149
  • 3Yano K, Reed D M, McGee D L, et al. Ten-year incidence of coronary heart disease in the Honolulu Heart Program.Relationship to biologic and lifestyle characteristic [J]. Am Epidemiol, 1984,119 (5) : 653
  • 4刘力生.2004年中国高血压防治指南(实用本)[J].中华心血管病杂志,2004,32(12):1060-1064. 被引量:2619
  • 5Wise C M, Agudelo C A. Gouty arthritis and uric acid metabolism[J]. Curr Opin Rheumatol, 1996,8(3):248
  • 6Wong N D, Pio J, Valenica R, et al. Distribution of C-reactive protein and its relation to risk factors and coronary heart disease risk estimation in the National Health and Nutrition Examination Survery (NHANES)Ⅲ[J]. Prey Cardiol,2001,4(3) : 109
  • 7Ward H J. Uric acid as an independent risk factor in the treatment of hypertension[J]. Lancet, 1998,352(12) : 670
  • 8DeScheeder I K, van de Kraay A M, lamers J M, et al.Myocardial malodialdehyde and uric acid release after short-lasting coronary occlusions during angiopiasty: potential mechanisms for free radical generation[J]. Am J cardiol,1991,68(2) :392
  • 9Ginsberg M H, Kozin F, O'Malley M, et al. Release of platelet constituents by monosodium urate crystals [J]. J Clin Invest,1997,60(12) :999
  • 10Tsutamoto T, Wada A, Maeda K. Angiotesis 2 type 1 receptor antagonist decrease plasma levels of tumor necrosis factor alpha,interleckin-6 and stable adhesion molecules in patients with chronic heart failure[J]. J Am Coil Cardiol,2000,35(6):714

共引文献2618

同被引文献169

引证文献24

二级引证文献153

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部